Axcelis Technologies, Inc. — Q3 2016 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2016; financial statements are unaudited. Axcelis makes ion-implantation and other semiconductor-processing equipment and provides related aftermarket products and services. Amounts below are in U.S. dollars.
Financial performance
| Metric | Q3 2016 | Q3 2015 | Nine months 2016 | Nine months 2015 |
|---|---|---|---|---|
| Revenue | $65.7 million | $79.3 million | $197.6 million | $231.0 million |
| Gross profit / margin | $24.1 million / 36.7% | $29.2 million / 36.8% | $72.7 million / 36.8% | $79.7 million / 34.5% |
| Operating income | $3.6 million | $7.7 million | $10.8 million | $18.3 million |
| Net income | $2.2 million | $6.1 million | $7.0 million | $13.9 million |
| Diluted EPS | $0.07 | $0.20 | $0.23 | $0.46 |
| Operating cash flow | Not separately presented for the quarter | $(13.0) million | $12.4 million |
- Q3 revenue fell 17.2% year over year; nine-month revenue declined 14.5%. Product revenue was down 19.6% in Q3 and 15.8% for the nine-month period, principally due to fewer Purion systems sold. Services revenue increased 15.0% in Q3 and 1.9% year to date.
- New-system revenue was $30.9 million in Q3 versus $47.0 million a year earlier; aftermarket revenue rose to $34.8 million from $32.3 million. For nine months, systems revenue was $101.6 million versus $131.1 million, while aftermarket revenue was $96.0 million versus $99.9 million.
- Gross margin was nearly flat in Q3, while nine-month margin improved 2.3 percentage points. Management attributed product margin gains to improved Purion margins and a richer mix of parts and upgrades; nine-month services margin also improved.
- At September 30, cash and cash equivalents were $65.6 million, plus $6.9 million of restricted cash. Current assets were $232.3 million and current liabilities $39.7 million. Operating cash use was driven mainly by working-capital movements, including receivables, inventory, and other assets and liabilities. Capital expenditures were $2.3 million.
- Total liabilities were $93.2 million. The principal financing obligation was the $47.6 million headquarters sale-leaseback obligation; the filing reports no credit facility. The company stated that existing cash was expected to meet anticipated short- and long-term requirements and that it believed borrowing could be available on reasonable terms if needed.
Material changes, outlook, and risks
- Management said Purion sales in the first three quarters declined due to lower DRAM-sector customer purchasing. It continued investing in Purion development and expected to grow Purion sales, gain market share, and improve gross margins; no quantified forward guidance was provided.
- Results remain exposed to semiconductor-equipment cycles, customer purchasing decisions, and changing capacity utilization. The ten largest customers generated 69.0% of nine-month revenue. Three customers represented 39.7% of Q3 revenue; two customers accounted for 43.0% of receivables at quarter-end.
- Operating cash flow shifted from $12.4 million provided in the prior-year nine-month period to $13.0 million used. The cash balance declined $13.3 million from year-end 2015.
- A first-quarter reduction in force, related to changes in customer service contracts following customer-base consolidation, resulted in $282,000 of nine-month restructuring charges; $15,000 remained accrued at September 30.
- The company corrected an immaterial prior-period inventory accounting error, reducing reported inventory and equity at December 31, 2015 by $6.5 million; management said it did not materially affect prior-period results or financial position. A 1-for-4 reverse stock split took effect June 30, 2016; share and per-share amounts were retrospectively adjusted.
- Management reported no litigation it believed could materially adversely affect operations and no material changes to previously disclosed risk factors. It reported effective disclosure controls. Revenue-recognition and lease accounting standards were still under evaluation.
Key facts for investors to verify
- Whether Purion demand, particularly from DRAM customers, recovers and supports management’s stated sales, market-share, and margin objectives.
- Whether working-capital investment and negative operating cash flow persist, and how cash and restricted-cash balances develop.
- The impact of customer concentration and semiconductor-industry cyclicality on future orders, revenue, and receivables collection.
- The economics and cash commitments associated with the 22-year headquarters lease and $47.6 million sale-leaseback obligation.
- The effect of the corrected inventory error and the upcoming adoption of revenue-recognition and lease-accounting standards.